An initiative to strengthen AI and life science for increased national competence

Knut and Alice Wallenberg Foundation allocates an additional SEK 600 million to data-driven life science. The total investment from the Foundation in the area now amounts to SEK 3.7 billion.

Research paving the way for new treatments for epilepsy, schizophrenia, and Alzheimer’s

A new way to treat neurological diseases such as Alzheimer’s, schizophrenia, and epilepsy could emerge from something that started as a failed experiment. Daniella Rylander Ottosson, from Lund University, entered the field of research surrounding a cell called Parvalbumin in this way. This little cell can be likened to a conductor – who makes sure that everyone is coordinated – that the flow of information takes place at the right pace. If the Parvalbumin cells are damaged or dead, the timing becomes inaccurate, and the signals fall out of sync. There is much to suggest that this could be one of the causes of diseases such as epilepsy, schizophrenia, and Alzheimer’s.